300+ investors in your industry, stage, and region Get
Any industry
Artificial Intelligence
Google
EdTech
Clean Energy
Retail
Enterprise Software
Local
Travel
Platforms
Oil and Gas
InsurTech
Cryptocurrency
Social Impact
SaaS
Film
Restaurants
Photography
Payments
Renewable Energy
Organic Food
Email
Fitness
CleanTech
Energy
Health Care
Machine Learning
Agriculture (AgTech)
Marketplace
Gaming
Facebook
Social Network
Blockchain
B2B
Big Data
Video Games
Education
Wellness
Medical Device
Mobile
Legal
Sports
Construction
Automotive
eSports
Hospitality
Biotechnology
Consumer
Software
Crowdfunding
Venture Capital
Social
Infrastructure
Fashion
Beauty
LGBT
Celebrity
Cannabis
Climate
Mobile Apps
Life Science
Publishing
Food and Beverage
Wine and Spirits
Real Estate
Sporting Goods
Art
Music
Finance
Digital Media
FinTech
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Mobile Advertising
Internet
Android
Impact
Biotech
Proptech
Sustainability
Hardware
Transportation
Enterprise
Community
Media (Entertainment)
Web3
Medical
Theatre
Recruiting
Any country
South Korea
Africa
Oceania
Brazil
Saudi Arabia
Singapore
LATAM
Greece
Gibraltar
Norway
Liberia
Mexico
Taiwan
Sweden
Nigeria
Isle of Man
Pakistan
Zambia
Romania
Puerto Rico
Tunisia
Russian Federation
Togo
Tajikistan
Zimbabwe
Colombia
Oman
Cameroon
Australia
India
New Zealand
China
Sri Lanka
Vietnam
Armenia
Costa Rica
Chile
Switzerland
Czech Republic
Kenya
Cayman Islands
Kuwait
Kazakhstan
Jamaica
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uganda
Turkey
Uzbekistan
Venezuela
Guatemala
Seychelles
Germany
Japan
South Africa
Egypt
France
Georgia
Denmark
Croatia
Hong Kong
Ghana
Iraq
Mali
Morocco
Myanmar
Latvia
Malaysia
Portugal
Philippines
Poland
Rwanda
Sierra Leone
Senegal
Thailand
El Salvador
Uruguay
Tanzania
United Kingdom
United States
Canada
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Cyprus
Qatar
United Arab Emirates
Spain
Angola
Europe
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Bahrain
Bahamas
Estonia
Faroe Islands
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Grenada
Israel
Honduras
Iceland
Cambodia
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Ireland
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Life Science Startup Investors in Switzerland (June 2026)

The most active venture capital funds and angel investors investing in Switzerland Life Science startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Switzerland Life Science startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Zürcher Kantonal Bank
VC Fund
6 Switzerland, Germany, Japan Seed, Series A Health Care, Medical Device, Biotechnology $1.2M–$14M
Foundation for Innovation and Technology (FIT)
VC Fund
4 Switzerland, France, United States Debt Financing, Grant, Seed Health Care, Biotechnology, Information Technology $23k–$1.2M
M Ventures
VC Fund
4 United States, United Kingdom, Switzerland Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $2.4M–$100M
Eclosion SA
VC Fund
4 Switzerland Seed, Series C Biotechnology, Pharmaceutical, Health Care $1.6M–$28M
EQT Life Sciences
VC Fund
4 United States, The Netherlands, Switzerland Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $6.9M–$165M
Verve Ventures
VC Fund
3 Switzerland, Germany, France Series A, Seed, Series B Health Care, Software, Biotechnology $1.4M–$43M
Novartis Venture Fund
VC Fund
3 United States, Switzerland, United Kingdom Series B, Series A, Series C Biotechnology, Health Care, Therapeutics $5.1M–$120M
Pfizer Venture Investments
VC Fund
3 United States, United Kingdom, Switzerland Series B, Series A, Series C Biotechnology, Health Care, Therapeutics $10M–$123M
ACE Ventures
VC Fund
2 Switzerland, United States, United Kingdom Seed, Series A, Pre-Seed Life Science, Information Technology, Artificial Intelligence $6M–$18M
Sunstone Life Science Ventures
VC Fund
2 Denmark, Sweden, Switzerland Series B, Series A Biotechnology, Health Care, Medical $5.5M–$52M
Founderful
VC Fund
2 Switzerland, United Kingdom, Canada Pre-Seed, Seed, Series A Software, Artificial Intelligence, Information Technology $1.1M–$24M
BlueOcean Ventures
VC Fund
2 Switzerland, India, France Seed, Series A Health Care, Medical, Personal Health $1M–$20M
SOSV
VC Fund
2 United States, India, United Kingdom Seed, Convertible Note, Pre-Seed Biotechnology, Health Care, Software
BioMedPartners
VC Fund
2 Switzerland, Germany, France Series A, Series B, Series C Biotechnology, Health Care, Medical $4.9M–$83M
VINCI CAPITAL
VC Fund
2 Switzerland, Germany Series A, Series B Medical, Health Care, Biotechnology $8.6M–$36M
HTGF (High-Tech Gruenderfonds)
VC Fund
2 Germany, Switzerland, United States Seed, Series A Software, Biotechnology, Information Technology $994k–$40M
Kinled Holding
VC Fund
2 United Kingdom, United States, Switzerland Seed, Series A Biotechnology, Health Care, Software $648k–$40M
Fongit Seed Invest
VC Fund
2 Switzerland Seed, Series A, Series B Health Care, Medical, Biotechnology $1.2M–$3.7M
Rheingau Founders
VC Fund
2 Germany, United States, Poland Seed, Series A, Pre-Seed Software, E-Commerce, Internet $110k–$14M
Omega Funds
VC Fund
2 United States, Switzerland, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $14M–$208M
Versant Ventures
VC Fund
2 United States, Switzerland, Canada Series A, Series B, Series C Biotechnology, Health Care, Medical $4.7M–$108M
EFI Lake Geneva Ventures
VC Fund
2 Switzerland, Germany Seed, Pre-Seed, Series A Health Care, Life Science, Medical $2.7M–$4M
FAST — by GETTYLAB
VC Fund
2 United States, United Kingdom, France Pre-Seed, Seed Software, Biotechnology, Health Care $125k–$7.6M
Lichtsteiner Foundation
VC Fund
2 Switzerland Seed, Series A Biotechnology, Health Care, Medical $1.6M–$7.2M
Idinvest Partners
VC Fund
1 France, United States, Spain Series B, Series A Biotechnology, Health Care, Software $3.3M–$66M
Think.Health
VC Fund
1 Germany, United States, Switzerland Seed, Series A, Series B Health Care, Biotechnology, Medical Device
Blue Owl
VC Fund
1 United States, United Kingdom, Canada Debt Financing, Post-IPO Equity, Series B Biotechnology, Health Care, Pharmaceutical
SR One
VC Fund
1 United States, United Kingdom, Canada Series A, Series B, Series C Biotechnology, Health Care, Therapeutics
Gaingels
VC Fund
1 United States, Canada, United Kingdom Seed, Series A, Series B Software, Health Care, Artificial Intelligence
Indaco Venture Partners
VC Fund
1 Italy, Switzerland, United States Series A, Series B Biotechnology, Health Care, Life Science
Acequia Capital (AceCap)
VC Fund
1 United States, United Kingdom, Switzerland Seed, Series A, Pre-Seed Software, Artificial Intelligence, Information Technology $620k–$25M
White Loop Capital
VC Fund
1 Switzerland Seed, Pre-Seed Finance, Software, Life Science
University of Zurich
VC Fund
1 Switzerland Series A Health Care, Life Science, Biotechnology
Skyviews Life Science
VC Fund
1 United States, Switzerland, United Kingdom Series B, Series A, Seed Biotechnology, Food and Beverage, Medical
UZH Life Sciences Fund
VC Fund
1 Switzerland Seed, Convertible Note Health Care, Biotechnology, Medical Device
LongeVC
VC Fund
1 United States, Estonia, Hong Kong Seed, Series A Biotechnology, Health Care, Therapeutics
AXA Alternative Investments
VC Fund
1 Kenya Agriculture, Biomass Energy, Renewable Energy
Mergus Ventures
VC Fund
1 Brazil, United States, Chile Seed, Pre-Seed Biotechnology, AgTech, Artificial Intelligence
OrbiMed
VC Fund
1 United States, China, Israel Series B, Series A, Series C Biotechnology, Health Care, Medical
Pivotal bioVenture Partners
VC Fund
1 United States, China, Canada Series B, Series C, Series A Biotechnology, Pharmaceutical, Health Care
RTW Investments
VC Fund
1 United States, Switzerland, China Post-IPO Equity, Series B, Series C Biotechnology, Health Care, Therapeutics
The Helm
VC Fund
1 United States, Switzerland Seed, Series A Health Care, Communities, E-Commerce
Recipharm Venture Fund
VC Fund
1 Sweden, Switzerland Series A Biotechnology, Medical, Health Care
Kickfund
VC Fund
1 Switzerland Seed, Pre-Seed, Convertible Note Biotechnology, Renewable Energy, Manufacturing
JFG Life Sciences Foundation
VC Fund
1 Switzerland Seed Biopharma, Health Care, Biotechnology
Amboy Street Ventures
VC Fund
1 United States, Canada, Sweden Series A, Seed, Pre-Seed Health Care, Wellness, Women's
Simon Fiduciaria
VC Fund
1 Italy, United Kingdom Seed, Series B Therapeutics, Simulation, Biotechnology
Ysios Capital
VC Fund
1 Spain, United States, Switzerland Series A, Series B, Series C Biotechnology, Health Care, Medical
Primal Capital
VC Fund
1 Japan, Spain, Switzerland Seed, Pre-Seed Software, Information Technology, Internet
Bruker
VC Fund
1 United States, Switzerland Series A, Seed Biotechnology, Medical, Health Care
Access all 182 investors in Switzerland Life Science startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Zürcher Kantonal Bank
VC Fund · Zürich, Zurich, Switzerland · 6 investments in Switzerland Life Science startups

Zürcher Kantonalbank is an independent, incorporated public-law institution is its public service mandate. Enshrined in law, it governs the bank's economic, social, and environmental commitment.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Biotechnology
  • Stage:Seed, Series A
  • Geography: Switzerland, Germany, Japan

Investor stats

  • Total investments: 187
  • Round size: Seed $1.2M–$6M; Series A $2.3M–$14M
  • Lead/follow: 13% lead, 87% follow

Portfolio highlights

  • TestResults — TestResults uses the TrueTest technology and AI-based virtual user that makes it possible for the first time to test autonomously across software, system, and technology boundaries from a user perspective with the same approach. The company has simplified automated testing massively and reduced time radically. With it, the automation andmaintenance effort is reduced to a minimum that allows zero flakiness and the enlightening feeling of being in control of automation and test scenarios.
  • QualySense — QualySense is a Swiss start-up company focused on innovative high-throughput grain, beans and seeds sorting technology. QualySense develops a high-speed multi-tons per hour sorting device, which will change how grains, beans and seeds are processed and valued worldwide by assessing the biochemical quality of grains one by one. The QualySensesorters will enable customers to separate grain batches into different biochemical quality classes and sell the corresponding premium products at higher average prices. Food processors will be able to considerably increase the production value, and produce higher quality products in a non-interrupted process.
  • Pearltec AG — Headquartered in Schlieren / Zurich, Pearltec AG develops, produces and delivers solutions for the optimal storage, fixation and positioning of patients. Their products are based on unique, patented technology developed in collaboration with ETH Zurich and renowned university hospitals.They have set theirselves the goal to use the technologycompetence of Pearltec AG for the benefit of humans, animals and industry and to create added value for their customers by excellent quality and convincing application advantages.Pearltec AG is certified according to ISO standard 13485. This certification certifies that their quality management system for the development and manufacture of medical devices meets the highest international standards.
Show all investments...

Foundation for Innovation and Technology (FIT)
VC Fund · Lausanne, Vaud, Switzerland · 4 investments in Switzerland Life Science startups, 22 in the past 12 months

The Foundation for Technology Innovation gives financial assistance to creative and technological projects at various phases of development. FIT funds projects in energy and the environment, information and digital technology, life sciences and health, precision industries, and nutrition and agriculture.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Information Technology
  • Stage:Debt Financing, Grant, Seed
  • Geography: Switzerland, France, United States

Investor stats

  • Total investments: 167
  • Round size: Seed $117k–$1.2M; Grant $23k–$125k; Debt Financing $100k–$583k
  • Lead/follow: 93% lead, 7% follow

Portfolio highlights

  • Phonemia — Phonemia is a digital health company that offers artificial intelligence and speech therapy services.
  • MoleSense — Developing continuous molecular monitoring wearables to enable proactive healthcare.
  • DiverSsiTy SA — DiverSsiTy SA develops personalized, patient-centric digital health technologies (DHTs) to improve the lives of patients suffering from neurodevelopmental disorders (NDDs), among which are those with autism spectrum disorder (ASD) and related comorbidities like attention-deficit/hyperactivity disorder (ADHD).
Show all investments...

M Ventures
VC Fund · Amsterdam, Noord-Holland, The Netherlands · 4 investments in Switzerland Life Science startups

Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: United States, United Kingdom, Switzerland

Investor stats

  • Total investments: 170
  • Round size: Seed $2.4M–$22M; Series A $5.6M–$49M; Series B $15M–$100M
  • Lead/follow: 38% lead, 62% follow

Portfolio highlights

  • Anjuna — Anjuna confidential cloud software establishes a secure enclave that isolates and encrypts applications and data in runtime, at rest, and on the network for end-to-end data protection
  • Biolinq — Introducing a revolutionary platform for metabolic health.
  • Asceneuron — Asceneuron develops effective therapeutics for orphan tauopathies and Alzheimer’s disease. By focusing on areas of high unmet medical need, Asceneuron aspires to become a leading biotech company specialized in small molecule drug discovery for neurodegenerative diseases.Tauopathies are currently untreatable neurodegenerative diseases thatrapidly progress towards debilitating conditions. The appearance of deposits of the microtubule-associated tau protein as e.g. neurofibrillary tangles in neurons of the brain is a common feature of tauopathies that is shared with Alzheimer’s disease. Neuronal tau deposits are known to be a major contributor to neurodegeneration and mutations in the tau gene are causative of the tauopathy fronto-temporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).Due to increasing life expectancy, Alzheimer’s disease is viewed as one of the largest healthcare problems of this century, imposing a major economic burden on societies in the Western and developing world. Current treatment options provide limited benefits supporting the urgent need for more efficacious and better tolerated medicines that address symptomatic relief as well as disease progression.
Show all investments...

Eclosion SA
VC Fund · Geneva, Geneve, Switzerland · 4 investments in Switzerland Life Science startups

Eclosion assists entrepreneurs with the necessary resources to bridge the gap between their laboratories and the stage where the start-up

Show more...

Investment focus

  • Industry: Biotechnology, Pharmaceutical, Health Care
  • Stage:Seed, Series C
  • Geography: Switzerland

Investor stats

  • Total investments: 16
  • Round size: Seed $1.6M–$2.7M; Series C $20M–$28M
  • Lead/follow: 56% lead, 44% follow

Portfolio highlights

  • KYLYS — KYLYS is an innovative Swiss company based in Geneva founded in March 2017. KYLYS provides people and patients with highly effective and safe products based on biomolecules.
  • Genkyotex — Genkyotex is dedicated to the development of innovative drugs which block enzymes that produce oxygen radicals. Such novel drugs will allow the treatment of oxygen-radical mediated acute and chronic diseases, with improved specificity, safety, and efficacy over existing antioxidants therapy, giving them a significant competitive advantage.Genkyotex targets its technology initially to the therapeutic areas of cardiovascular, metabolic and neurodegenerative diseases.
  • MPC Therapeutics — MPC Therapeutics develops a novel class of compounds with application in Immunotherapy and Metabolic diseases
Show all investments...

EQT Life Sciences
VC Fund · Amsterdam, Noord-Holland, The Netherlands · 4 investments in Switzerland Life Science startups

Providing capital plus strategic, clinical, operational, financial, and commercial support to deliver the added value inventors seek.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, The Netherlands, Switzerland

Investor stats

  • Total investments: 174
  • Round size: Series A $6.9M–$77M; Series B $12M–$103M; Series C $12M–$165M
  • Lead/follow: 41% lead, 59% follow
  • Last fund: Likely still investing — raised $266M in 2023

Portfolio highlights

  • Perfuze — Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. Perfuze is located within Galway City in the West of Ireland. The founders have over 30 years combined medtech experience within start-up and large corporations.Perfuze is developing innovative medical technology to treat acute ischemic stroke.Perfuze is developing innovative cathetertechnology to treat acute ischemic stroke. Their technology is intended to provide superior clinical outcomes in shorter procedural times; resulting in safe, cost-effective therapy. Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. The founders have over 30 years combined medtech experience within start-up and large corporations. Perfuze is currently located in the Business Innovation Centre on the campus of the National University of Ireland, Galway, and is in the process of relocating to the IDA Business Park in Dangan, Galway.
  • Neuros Medical — Neuros Medical is a neuromodulation company, is focused on developing proprietary therapies for the unmet needs of patients worldwide. The Company's patented platform technology, Electrical Nerve Block, is focused on the elimination of chronic pain in a variety of applications including neuroma/residual limb pain, chronic post-surgicalpain, and chronic migraine.
  • Simplify Medical — Simplify Medical designs, develops, and manufactures cervical artificial discs for use in the spine. It offers an MRI compatible motion preserving artificial cervical disc that is used to treat single level symptomatic cervical disc disease.The company provides its products for skeletally mature patients for reconstruction of the disc at onelevel from C3-C7 following single-level discectomy for intractable radiculopathy, such as arm pain or a neurological deficit.Simplify Medical was founded in 2015 and is based in Mountain View, California.
Show all investments...

Verve Ventures
VC Fund · Zug, Zug, Switzerland · 3 investments in Switzerland Life Science startups

Verve Ventures has invested in more than 140 science and technology startups. We support visionary and resilient entrepreneurs from day one and are a reliable partner for the entire journey. We typically invest EUR 1-3m in early as well as later stage rounds of European high tech startups.

Show more...

Investment focus

  • Industry: Health Care, Software, Biotechnology
  • Stage:Series A, Seed, Series B
  • Geography: Switzerland, Germany, France

Investor stats

  • Total investments: 260
  • Round size: Seed $1.4M–$10M; Series A $2.3M–$17M; Series B $4.2M–$43M
  • Lead/follow: 14% lead, 86% follow
  • Last fund: Likely still investing — raised $66M in 2022

Portfolio highlights

  • Sleepiz — Sleepiz is a Zürich based startup with the aim to enable the medical community to take healthcare into the home environment. Sleepiz provides an easy and comfortable to use solution with a device that is simply placed on the bedside table. The device operates in a non-contact fashion and measures movements originating from heart contractions andbreathing patterns as well as body motions with medical grade accuracy.By making use of wireless millimeter wave technology, sensor fusion and artificial intelligence Sleepiz will in the future not only able to diagnose sleep disorders, but also to perform long-term monitoring. Thereby, the progression of chronic diseases can be monitored to allow faster intervention and better treatment.
  • Biograil — Biograil, founded in 2019 and led by CEO Karsten Lindhardt, is using injection molding to manufacture a device contained in a standard size capsule able to deliver active substances into the gastrointestinal wall. The Biograil device avoids mechanical moving components and makes use of the body’s own peristaltic forces to facilitate the delivery ofthe biologic efficiently into the gastrointestinal wall.
  • iMusician — iMusician offers music distribution, promotion, mastering, and monetization for independent musicians & labels. Get on Spotify, Apple Music, Amazon, TikTok & many more.
Show all investments...

Novartis Venture Fund
VC Fund · Basel, Basel-Stadt, Switzerland · 3 investments in Switzerland Life Science startups

Learn about the approach the Novartis Venture Fund takes to investing in innovative life science companies developing biotechnology and biopharmaceutical therapeutics that address unmet patient needs.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series B, Series A, Series C
  • Geography: United States, Switzerland, United Kingdom

Investor stats

  • Total investments: 213
  • Round size: Series A $5.1M–$81M; Series B $11M–$120M; Series C $9M–$75M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: May invest from a new fund soon — raised $200M in 2009

Portfolio highlights

  • Splice Bio — Splice Bio is a gene therapy company based on technology developed in the Muir Lab at Princeton University. The company is developing novel gene therapies based on its proprietary intein platform technology to treat patients that suffer from incurable genetic diseases. The company’s platform has the potential to address two existing limitations ofadeno-associated viruses (AAVs), both by increasing the size of the cargo gene that can be delivered and by expanding the range of tissues that can be targeted.
  • Bionano Genomics — Discover how Bionano is striving to elevate health and wellness for all through optical genome mapping (OGM) solutions that transform the way the world sees the genome.
  • LOQUS23 THERAPEUTICS — LoQus23 is a DDF-formed company focussing on targeting DNA damage repair pathways to treat Huntington’s disease and other triplet repeat diseases.
Show all investments...

Pfizer Venture Investments
VC Fund · New York, New York, United States · 3 investments in Switzerland Life Science startups

Pfizer Venture Investments is a corporate venture capital firm that invests in areas of current or future strategic interest to Pfizer. It aims to remain at the forefront of life science advances. It identifies and invests in emerging companies that are developing transformative medicines and technologies that have the potential to enhance Pfizer’spipeline and shape the future of its industry.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series B, Series A, Series C
  • Geography: United States, United Kingdom, Switzerland

Investor stats

  • Total investments: 167
  • Round size: Series A $10M–$100M; Series B $20M–$123M; Series C $15M–$102M
  • Lead/follow: 28% lead, 72% follow
  • Last fund: May invest from a new fund soon — raised $600M in 2018

Portfolio highlights

  • Neuronetics — Antidepressant medications don't work for everyone. If drugs haven't worked for you, learn about NeuroStar - safe, effective, lasting TMS therapy for depression.
  • Pyxis Oncology — Charting a course to therapeutics for difficult-to-treat cancers.
  • Triana Biomedicines — Triana Biomedicines is building the leading molecular glue discovery platform to regulate disease targets that are difficult to address with any other modality. Triana’s drug discovery engine is powered by high- resolution structural insights, state-of-the-art in silico tools, and bespoke chemical libraries. The research team has validated thebest-in-class platform and initiated multiple programs across different disease areas.
Show all investments...

ACE Ventures
VC Fund · London, England, United Kingdom · 2 investments in Switzerland Life Science startups

ACE Ventures is a Swiss-based, early-stage VC firm partnering with the next generation of Swiss tech founders who are building transformative businesses, both in Switzerland and abroad.

Show more...

Investment focus

  • Industry: Life Science, Information Technology, Artificial Intelligence
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Switzerland, United States, United Kingdom

Investor stats

  • Total investments: 6
  • Round size: Seed $8M–$8M; Series A $6M–$18M
  • Lead/follow: 67% lead, 33% follow

Portfolio highlights

  • Veezoo — Veezoo empowers individuals to find actionable insights from data by literally just asking questions in plain English!
  • Scholé — AI-native personalized learning
  • Zyrnex AI — Zyrnex AI developed the first ever AI test engineers, addressing the severe shortage in test automation. This helps companies achieve quality across their digital offerings in no time. The AI test engineers are available instantly in any number required and can create test automation projects for any number of scenarios in parallel in amatterofminutes. They are unique to the market in that they are capable of creating test automation for multilingual websites and apps as well as for any screen size including computer, tablet and mobile.
Show all investments...

Sunstone Life Science Ventures
VC Fund · Copenhagen, Hovedstaden, Denmark · 2 investments in Switzerland Life Science startups

Sunstone Life Science Ventures is an independent European venture capital investment firm. We enable and empower life science therapeutics innovations.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A
  • Geography: Denmark, Sweden, Switzerland

Investor stats

  • Total investments: 56
  • Round size: Series A $5.5M–$43M; Series B $9.6M–$52M
  • Lead/follow: 14% lead, 86% follow
  • Last fund: May invest from a new fund soon — raised $94M in 2019

Portfolio highlights

  • Teitur Trophics — Teitur Trophics is a biotech company developing circular peptides for neurodegenerative diseases. The company was founded in 2020 and is headquartered in Aarhus, Denmark.
  • Synendos Therapeutics — Synendos Therapeutics is a biopharmaceutical company that aims to develop breakthrough safe and effective therapies for unmet needs in neuropsychiatric disorders through modulation of a new drug target in the endocannabinoid system that enables restoration of natural functioning of the brain.
  • TargED Biopharmaceuticals — TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Founderful
VC Fund · Zürich, Zurich, Switzerland · 2 investments in Switzerland Life Science startups

Founderful operates as a venture capital firm and a Switzerland’s leading pre-seed fund.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Pre-Seed, Seed, Series A
  • Geography: Switzerland, United Kingdom, Canada

Investor stats

  • Total investments: 96
  • Round size: Seed $1.5M–$16M; Pre-Seed $1.1M–$3.8M; Series A $3.4M–$24M
  • Lead/follow: 54% lead, 46% follow
  • Last fund: Likely still investing — raised $85M in 2024

Portfolio highlights

  • EthonAI — Ethon is the #1 Industrial AI platform, built to turn production data into business value. It empowers engineers and operators with agentic workflows to understand, improve, and control their production processes.
  • AVIAN
  • Flink — Drop-in robots for logistics operations. Handle any object, anywhere, autonomously. Enabled by our physical intelligence layer.
Show all investments...

BlueOcean Ventures
VC Fund · Plan-les-ouates, Geneve, Switzerland · 2 investments in Switzerland Life Science startups

BlueOcean Ventures SA provides capital, operational and company development advisory support (mentoring, company management, divestment experience, network, negotiation support) to entrepreneurs in Switzerland. BlueOcean Ventures is based in Geneva, Switzerland.

Show more...

Investment focus

  • Industry: Health Care, Medical, Personal Health
  • Stage:Seed, Series A
  • Geography: Switzerland, India, France

Investor stats

  • Total investments: 17
  • Round size: Seed $1M–$3M; Series A $2.3M–$20M
  • Lead/follow: 29% lead, 71% follow

Portfolio highlights

  • Augurix — Just another WordPress site
  • Mikajaki — Mikajaki is an innovative automated multi-patient ocular diagnostics platform. The platform enables the use of digital technology, robots, AI, and data, allowing patients and eye specialists access to the specific treatment they require. Mikajaki is currently collaborating with ophthalmology clinic groups across the world to test and implementEyeLib.
  • official.fm — At Official.fm, they develop powerful music promotion tools for you, whether you're an emerging artist or an accomplished label.They make it easy to manage a few tracks or a large catalog, create pages and players that look like you and share them across your favorite promotion platforms and social networks, all the while collectinginsightful analytics. Improving your workflow is their top priority.Promoting your music with official.fm will always be free. Music promotion is an investment for you and it is one for us too. Now you also have the ability to sell directly music to your fans. Soon they will offer more ways for your to generate revenue from your music.
Show all investments...

SOSV
VC Fund · Princeton, New Jersey, United States · 2 investments in Switzerland Life Science startups, 75 in the past 12 months

SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Convertible Note, Pre-Seed
  • Geography: United States, India, United Kingdom

Investor stats

  • Total investments: 1482
  • Lead/follow: no public data

Portfolio highlights

  • MixRift — MIXRIFT - game developers specialized in Mixed Reality
  • unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
  • Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Show all investments...

BioMedPartners
VC Fund · Basel, Basel-Stadt, Switzerland · 2 investments in Switzerland Life Science startups

BioMedPartners is one of the leading European venture capital firms providing private equity and mezzanine financing to early- and mid-stage healthcare and human life science companies. They target the entire industry with special focus on pharmaceuticals, biotechnology, diagnostics and medical technology.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: Switzerland, Germany, France

Investor stats

  • Total investments: 87
  • Round size: Series A $5.3M–$26M; Series B $4.9M–$83M; Series C $5.8M–$48M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: May invest from a new fund soon — raised $113M in 2018

Portfolio highlights

  • Vaximm — Vaximm is focused on developing active immunotherapies (vaccines) for patients suffering from cancer. Their initial product candidate VXM01 is targeting the tumor vasculature, which is essential for tumors to grow beyond microscopic size. Vaximm has shown impressive anti-tumor activity in various animal studies and will enter first human clinicaltrials in 2011.
  • iDEL Therapeutics — iDEL Therapeutics is advancing a new class of cancer medicines by delivering therapeutic payloads directly into the cytosol of tumor cells through a unique, pan-cancer uptake mechanism.
  • Affimed — At Affimed, they are committed to improving outcomes for patients with cancer. Their scientific team has been devoted to unlocking the power of the innate immune system for nearly two decades to provide a unqiue approach to fighting cancer. With their unparalleled expertise in innate immunity and innate cell engager-based medicines, they aim toovercome the limitations and challenges faced by current immuno-oncology (I-O) therapies.
Show all investments...

VINCI CAPITAL
VC Fund · Lausanne, Vaud, Switzerland · 2 investments in Switzerland Life Science startups

Vinci Capital is a leading Swiss private equity firm with over MCHF 200 under management. Since 1998 they have provided equity to over 30 Swiss technology and industrial companies to finance innovation, growth and succession-buyouts.Their investment team capitalizes on 40 years of cumulated experience in private equity and a solid operationalbackground in growth, turn-around, consolidation, IPOs and M&A situations.

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Series A, Series B
  • Geography: Switzerland, Germany

Investor stats

  • Total investments: 15
  • Round size: Series A $8.6M–$20M; Series B $21M–$36M
  • Lead/follow: 27% lead, 73% follow
  • Last fund: May invest from a new fund soon — raised $10M in 2012

Portfolio highlights

  • Anergis — Anergis, a clinical-stage biopharmaceutical company, discovers and develops allergy vaccines based on the technology of Contiguous Overlapping Peptides for ultra-fast desensitization. It offers vaccines against birch pollen, ragweed pollen, and house dust mite allergies. Francois Spertini founded Anergis in 2001. Its headquarters in Lausanne inSwitzerland.
  • SENSIMED — Sensimed designs, develops, and commercializes integrated micro-systems for medical devices. The company’s product portfolio includes SENSIMED Triggerfish, a product that offers an automated recoding of continuous ocular dimensional change over 24 hours. Sensimed is now focused on expanding the knowledge of how this individual data can best beused in the clinical setting to deliver customized treatment. The 24 hour profiles are being centralized on a registry together with patient and treatment information. The data is being analyzed and modeled on an ongoing basis in an attempt to identifying pathological patterns that can be used to differentiate indication, personalize treatment and assess efficacy following treatment.Sensimed was founded by Matteo Leonardi and Sacha Cerboni in August 2003 and is based in Lausanne, Switzerland.
  • Beqom — beqom is a Total Compensation Management Software Solution focused exclusively on managing compensation & performance for HR & Sales.
Show all investments...

HTGF (High-Tech Gruenderfonds)
VC Fund · Bonn, Nordrhein-Westfalen, Germany · 2 investments in Switzerland Life Science startups

High-Tech Grunderfonds finances startups with growth potential. Its team of investment managers supports young companies with expertise, entrepreneurial spirit, and passion. The company focuses in the fields of digital tech, industrial tech, life sciences, chemistry, and related business areas. It also focuses on financial services in varioussectors.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Information Technology
  • Stage:Seed, Series A
  • Geography: Germany, Switzerland, United States

Investor stats

  • Total investments: 557
  • Round size: Seed $994k–$7.4M; Series A $3M–$40M
  • Lead/follow: 34% lead, 66% follow
  • Last fund: Likely still investing — raised $522M in 2022

Portfolio highlights

  • QphoX — QphoX builds quantum modem device, connecting quantum computers across a quantum network.
  • Zimory — Founded in 2007, Zimory provides carrier-grade cloud infrastructure management software that allows service providers, enterprises and cloud brokers to fully leverage the power and elasticity of cloud computing. Zimory’s intelligent Cloud Suite simplifies, automates and expedites the creation, launch and management of all types of cloudenvironments – whether public, private, virtual private or hybrid. Zimory software is also a key enabler of cloud marketplaces for enterprise services, applications and infrastructure. Headquartered in Berlin, Zimory has development centers in Erfurt, Germany and Minsk, Belarus, a subsidiary office in New York City and is expanding its expertise and presence globally.
  • BlueID GmbH — Smart locks for professionals. BlueID delivers flexible, secure and convenient smart locks for all doors in and around your office.
Show all investments...

Kinled Holding
VC Fund · New York, New York, United States · 2 investments in Switzerland Life Science startups

Kinled was founded in 1980 to retain the investment assets of the Aisher family.In 1990, the investment focus shifted to a portfolio of early stage investments applying Kinled’s company development experience alongside the endurance and passion of family owned investments together with the strategic focus of venture capitalists.Since then,Kinled has taken 8 companies to public markets and many more to successful trade sales at significant multiples.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, Switzerland

Investor stats

  • Total investments: 117
  • Round size: Seed $648k–$11M; Series A $2M–$40M
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • Esper — Esper is the first cloud-based platform to help governments proactively manage public policy with better data and transparency.
  • Q.ANT — Q.ANT develops photonic processors for AI and high-performance computing, utilizing light for information processing. The company also produces quantum sensors offering ultra-high magnetic field sensitivity in a compact form factor. These products aim to enable more intelligent and sustainable systems across various sectors like data centers,aerospace, and medical technology.
  • PreComb — PreComb develops technologies to optimally adapt the therapies to each patient for difficult to treat cancers to increase the success rates in cancer therapy. Only an efficient use of healthcare resources can lead to a maximum improvement in the quality of life of patients.
Show all investments...

Fongit Seed Invest
VC Fund · Plan-les-ouates, Geneve, Switzerland · 2 investments in Switzerland Life Science startups

Fongit Seed Invest (FSI) is the leading Seed Money Fund of Switzerland for young technology companies. It provides smart seed capital.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Seed, Series A, Series B
  • Geography: Switzerland

Investor stats

  • Total investments: 9
  • Round size: Seed $1.2M–$1.4M; Series A $2.3M–$3.7M
  • Lead/follow: 56% lead, 44% follow

Portfolio highlights

  • EBAMed — EBAMed SA is a Swiss startup based in Geneva whose mission is to enable safe and effective non-invasive treatments of heart arrhythmias with protontherapy. The company is currently developing a medical device to enable non-invasive heart motion imaging and real-time synchronization of the therapeutic beam. This device consists in both hardware andsoftware components and expands treatment possibilities for existing protontherapy centres, enabling them for the first time to treat heart patients.
  • Gmelius — Gmelius is the world's first 360 email collaboration platform designed for Gmail and your company's daily apps. Join the async movement!
  • Annaida Technologies — Empowering fertility providers and researchers with AI-driven metabolomic platforms. Non-invasive, real-time insights at the microscale for personalized medical treatments.
Show all investments...

Rheingau Founders
VC Fund · Berlin, Berlin, Germany · 2 investments in Switzerland Life Science startups

Rheingau Founders is a Berlin&Munich based Venture Capital firm active since 2011. Focusing on pre-seed to Series A investments in Europe, predominantly B2B in the fields of Marketplaces, Software as a Service, InsurTech, and eHealth. Rheingau targets start-ups that have the potential to sustainably disrupt existing processes and value chains.Besides the financial investment, we offer strategic support through the mentorship of our partners.

Show more...

Investment focus

  • Industry: Software, E-Commerce, Internet
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Germany, United States, Poland

Investor stats

  • Total investments: 84
  • Round size: Seed $110k–$6.3M; Pre-Seed $770k–$2.9M; Series A $2.4M–$14M
  • Lead/follow: 27% lead, 73% follow

Portfolio highlights

  • MoleQlar — MoleQlar is a data and research-driven longevity company. It provides valuable information and offers consumers lab-tested nutritional supplements. The company focuses on functional medicine with optimized nutrition. Their product range includes Uthever NMN, Resveratrol, Betaine, Carnosine, and more. These products are aimed at lowering biologicalage and promoting health and longevity. MoleQlar also offers health tracking services. The company is certified in Germany and delivers its products EU-wide, including Switzerland.
  • Qualifyze — Qualifyze (former ChemSquare) was founded out of the Technical University of Darmstadt in September 2017. Today, we are based in Frankfurt am Main, the heart of Germany’s pharmaceutical cluster, where the leading life science companies are based. Our team consists of 16 people with diverse backgrounds and areas of expertise in business,engineering, and technology as well as several strategic partners from the pharma, food and cosmetics industry.
  • Akhetonics — Creating the first all-optical RISC Processor
Show all investments...

Omega Funds
VC Fund · Boston, Massachusetts, United States · 2 investments in Switzerland Life Science startups

We aim to invest in exceptional founders and entrepreneurs and impactful products and platforms across multiple therapeutic areas.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, Switzerland, United Kingdom

Investor stats

  • Total investments: 149
  • Round size: Series A $16M–$197M; Series B $35M–$162M; Series C $14M–$208M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • Ousia Pharma — Ousia Pharma is paving the way for novel therapeutic strategies using peptide-drug-conjugates
  • Andrew Alliance — OneLab is laboratory software to design and execute liquid handling protocols. Pipette+ for manual liquid handling pipetting and Andrew+ the pipetting robot
  • NRG Therapeutics — energizing drug discovery in neurodegenerative diseases.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Versant Ventures
VC Fund · Menlo Park, California, United States · 2 investments in Switzerland Life Science startups

Versant partners with exceptional entrepreneurs to build and fund breakthrough biotechnology companies around the globe.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: United States, Switzerland, Canada

Investor stats

  • Total investments: 282
  • Round size: Series A $4.7M–$80M; Series B $10M–$105M; Series C $12M–$108M
  • Lead/follow: 29% lead, 71% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • Stablix — Stablix is pioneering an entirely new field of targeted protein stabilization (TPS) to bring transformative medicines to patients with unmet medical need.
  • Passage Bio — Passage Bio, a genetic medicines company, is changing the future of CNS disorders and transforming the lives of patients and their families.
  • Lycia Therapeutics — Lycia Therapeutics is a biotechnology company that focuses on developing technology that utilizes lysosome-targeting chimeras. The company was founded by Carolyn R. Bertozzi in 2019 and is based in San Diego, California, USA.
Show all investments...

EFI Lake Geneva Ventures
VC Fund · Geneva, Geneve, Switzerland · 2 investments in Switzerland Life Science startups

EFI Lake Geneva Ventures is a seed and early-stage investment strategy based in Geneva, Switzerland. Founded in 2020, our mission is to foster innovation by investing at an early stage in fast-growing innovative Swiss companies in Technology, Life Sciences and Medtech.

Show more...

Investment focus

  • Industry: Health Care, Life Science, Medical
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Switzerland, Germany

Investor stats

  • Total investments: 6
  • Round size: Seed $2.7M–$4M
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • EBAMed — EBAMed SA is a Swiss startup based in Geneva whose mission is to enable safe and effective non-invasive treatments of heart arrhythmias with protontherapy. The company is currently developing a medical device to enable non-invasive heart motion imaging and real-time synchronization of the therapeutic beam. This device consists in both hardware andsoftware components and expands treatment possibilities for existing protontherapy centres, enabling them for the first time to treat heart patients.
  • Hylomorph — Hylomorph is a clinical-stage medical device company developing innovative materials designed to transform the biocompatibility of implantable medical devices.
  • Annaida Technologies — Empowering fertility providers and researchers with AI-driven metabolomic platforms. Non-invasive, real-time insights at the microscale for personalized medical treatments.
Show all investments...

FAST — by GETTYLAB
VC Fund · San Francisco, California, United States · 2 investments in Switzerland Life Science startups

Backing engineers building awe, wonder, speed.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Pre-Seed, Seed
  • Geography: United States, United Kingdom, France

Investor stats

  • Total investments: 100
  • Round size: Seed $1.9M–$7.6M; Pre-Seed $125k–$2.9M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Modelwise — Automated functional safety analysis via drag & drop. Seamless Integration. Faster Analyses. Zero Defects. More Savings.
  • Fluent Metal — Fluent Metal is a company that makes metal 3D printing economical, efficient, and safe.
  • Integrated Reasoning — Integrated Reasoning builds computer hardware to efficiently solve optimization problems. We're making faster and cheaper to solve problems like scheduling airline pilots or packing boxes into trucks.
Show all investments...

Lichtsteiner Foundation
VC Fund · Berne, Bern, Switzerland · 2 investments in Switzerland Life Science startups

Boosting health pioneers. We invest in early stage start-ups in different sectors: medtech, life science, biotech, mental health, public health, well-being.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A
  • Geography: Switzerland

Investor stats

  • Total investments: 10
  • Round size: Seed $1.6M–$7.2M
  • Lead/follow: 10% lead, 90% follow

Portfolio highlights

  • Hemostod — Developing universal platelets and next-generation diagnostics
  • DigeHealth — DigeHealth's approach to monitoring gut health using bowel noises and body measurements could provide some really valuable insights into digestive well-being.
  • Allegria Therapeutics — Allegria Therapeutics operates as a biotech company.
Show all investments...

Idinvest Partners
VC Fund · Paris, Ile-de-France, France · 1 investments in Switzerland Life Science startups

Idinvest Partners is a pan-European private equity manager focused on the low and middle-market segments. With over 6 billion euros under management, the company has developed several complementary areas of expertise, including equity investments in buyout deals focusing on both mid-size as well as young innovative European companies; primaryinvestments in European private equity funds focusing primarily on the middle market segment; secondary investments; mezzanine investments in Europe; and private equity consulting.Idinvest Partners’ recent success stories include Criteo, Clear2Pay, Meetic, Prosensa, Converteam, Kwik Fit, Lastminute.com, Dailymotion, Deezer, Talend, Synthesio, Menlook, Vestiaire Collective, Pretty Simple, Curse.com, Withings, Kantox, Secret Escapes, Happn, Peakon, Dayuse, Botify, Financefox, Azalead and many more.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Series B, Series A
  • Geography: France, United States, Spain

Investor stats

  • Total investments: 252
  • Round size: Series A $3.3M–$24M; Series B $7.8M–$66M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: May invest from a new fund soon — raised $88M in 2021

Portfolio highlights

  • Ornikar — Ornikar is an online driving school that offers radically cheaper, uncomplicated and faster offer to obtain a driving license.Ornikar relies on a network of state-qualified teachers to offer an apprenticeship in mobile driving at reduced prices. The cmpany is an an online driving school more in tune with the demand of current and futuregenerations.The company's mission is to make the driver's license exam cheaper and its learning more enjoyable.
  • Glovo — Glovo delivers the best products of your city in less than 1 hour
  • Stanley Robotics — Stanley Robotics is a DeepTech business helping the transportation and logistics industries digitalise and robotise outdoor operations.
Show all investments...

Think.Health
VC Fund · Fürstenfeldbruck, Bayern, Germany · 1 investments in Switzerland Life Science startups

Think.Health invests as a boutique risk-taker in healthcare ventures. We continuously seek innovations and disruptive business models in digital healthcare, medical technologies and health service providers,

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Seed, Series A, Series B
  • Geography: Germany, United States, Switzerland

Investor stats

  • Total investments: 34
  • Lead/follow: no public data

Portfolio highlights

  • Robeaute — Redesigning the future of neurosurgery by creating the new standard device that will provide surgeons with seamless access to delicate areas of the brain parenchyma and with real-time data.
  • Inflammatix — Inflammatix develops rapid point of care diagnostic tests by reading the immune system, and resolves major clinical health challenges.
  • Sphingotec GmbH — Improving patient outcomes with innovative diagnostics for critical care: Actionable insights in real-time
Show all investments...

Blue Owl
VC Fund · New York, New York, United States · 1 investments in Switzerland Life Science startups

Blue Owl is a leading asset management firm offering alternative investment solutions in private credit, GP stakes, and real assets.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Debt Financing, Post-IPO Equity, Series B
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 50
  • Lead/follow: no public data

Portfolio highlights

  • 6sense — Achieve predictable revenue growth with the 6sense Account Engagement Platform.
  • Neuron23 — Neuron23 is a developer of drugs intended to treat Parkinson's disease and Alzheimer's disease.
  • Big Brand Tire & Service — Big Brand Tire & Service is an automotive company that provides car maintenance, oil and filter change, brake services.
Show all investments...

SR One
VC Fund · Cambridge, Massachusetts, United States · 1 investments in Switzerland Life Science startups

SR One Capital Management is a leading trans-Atlantic biotech venture capital firm that partners with top entrepreneurs, scientists and investment partners to seek to build elite biotechnology companies. Our mission is to translate ground-breaking technologies into next generation medicines to benef

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 175
  • Lead/follow: no public data

Portfolio highlights

  • MiroBio — MiroBio's platform is based on ground-breaking research by their scientific founders at the University of Oxford delineating how immune cells communicate and how they are activated. These insights have enabled MiroBio to create antibodies that can leverage natural signalling mechanisms to restore immune system balance and control.
  • Bicycle Therapeutics — Bicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops which stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical need.The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.
  • MISSION Therapeutics — Deubiquitylating enzymes: multiple drug opportunities across therapeutic areas
Show all investments...

Gaingels
VC Fund · New York, New York, United States · 1 investments in Switzerland Life Science startups

Gaingels is a venture investment syndicate in service of the LGBT+ community and its allies, investing in companies with LGBT+ founders and C-suite leaders at all stages of growth, as well as in more established companies resolved on building more inclusive teams, with a global portfolio of 130+ companies and $70M in deployed investment capital todate. The Gaingels network also actively supports its portfolio in identifying and recruiting diverse talent to their C-suite and board leadership teams and fosters a vibrant global community of industry leaders, investors, operators, and entrepreneurs who share a common goal for positive social change through business and successful investments.

Show more...

Investment focus

  • Industry: Software, Health Care, Artificial Intelligence
  • Stage:Seed, Series A, Series B
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 629
  • Lead/follow: no public data

Portfolio highlights

  • Ashby — Ashby is a developer of recruitment software used for high-growth companies. It develops usable, enterprise-grade employment software that enables company leaders, recruiters, and hiring managers to run their hiring process significantly better. It was founded in 2018 and is based in San Francisco, California.
  • Paxton — Regulatory Intelligence, with the speed of Generative AI.
  • Viridian Space — Viridian Space develops a propulsion technology intended to use oxygen to stay in ultra-low earth orbit. The company was founded in 2021 and is based in Culver City, California.
Show all investments...

Indaco Venture Partners
VC Fund · Milan, Lombardia, Italy · 1 investments in Switzerland Life Science startups, 6 in the past 12 months

VENTURE We invest across all sectors with specific focus on technology and digital The largest independent more About Us Portfolio [...]

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Life Science
  • Stage:Series A, Series B
  • Geography: Italy, Switzerland, United States

Investor stats

  • Total investments: 41
  • Lead/follow: no public data

Portfolio highlights

  • Easy Rain — Easyrain pioneers active safety systems to prevent aquaplaning. We develop virtual sensors and hardware solutions to save lives on hazardous low-grip roads.
  • CamGraPhIC — Our platform supports the ever-increasing data traffic demand with high-performing and low-power consumption electro-optical engines.
  • Iama Therapeutics — At IAMA Therapeutics, we are constantly pushing the boundaries of neuroscience drug discovery to develop new medicines and make a difference in the lives of children suffering from brain disorders and their families. Our purpose is to provide a therapeutic solution to children suffering from neurological conditions and provide their families withthe support they need.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Acequia Capital (AceCap)
VC Fund · Seattle, Washington, United States · 1 investments in Switzerland Life Science startups

We are a leading early-stage investment platform. We are at the center of a global ecosystem that attracts and fuels the technical founders and product teams building the next wave of global businesses.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, United Kingdom, Switzerland

Investor stats

  • Total investments: 229
  • Round size: Seed $1.2M–$8M; Pre-Seed $620k–$3.3M; Series A $5M–$25M
  • Lead/follow: 7% lead, 93% follow
  • Last fund: May invest from a new fund soon — raised $4M in 2019

Portfolio highlights

  • Kindred — Kindred Labs is building the default interface for human–AI interaction — always-on, trusted companions that unify productivity, commerce, and emotional connection into a single relationship. As the only AI company officially trusted by 25+ iconic IPs, including Sanrio, Warner Bros., LINE Friends, and Pudgy Penguins, Kindred Labs sits on a uniquecultural and distribution moat powered by billions of existing fans worldwide.Kindred’s growth has been consistently explosive: the company has attracted millions of registered users within weeks of opening access, climbed into the Top 10 on DappRadar with hundreds of thousands of on-chain daily and monthly active users and millions of on-chain transactions in a single month, and driven an NFT free-mint that organically reached above a 1.3 ETH floor, alongside outsized gains in brand mindshare and category visibility (including a #1 gainer ranking on Kaito).Backers and partners include SEI Foundation, Protocol Labs, 0G Foundation, Techstars, Orange DAO, Sky Mavis, CoinMarketCap Labs, Nvidia Inception, ElevenLabs, and others. Kindred Labs is founded by Max Giammario, whose M.A./Ph.D.-level research focuses on human–AI interaction, and is built by a team of experts from companies such as Apple and Disney.
  • Doppler Labs — 2026's Top 5 Best Headphones Top Rated and Reviewed. Easily choose and compare the Best Headphones for you all in one place. (Fan Favorites)
  • Flow Engineering — Requirements management, made collaborative
Show all investments...

White Loop Capital
VC Fund · Lyon, Rhone-Alpes, France · 1 investments in Switzerland Life Science startups

White Loop Capital is the first investment firm specialized in crypto-assets in France. Accompanying those who dare.

Show more...

Investment focus

  • Industry: Finance, Software, Life Science
  • Stage:Seed, Pre-Seed
  • Geography: Switzerland

Investor stats

  • Total investments: 6
  • Lead/follow: no public data

Portfolio highlights

  • Ondefy — Ondefy is building infrastructure that enables a simple access to decentralized finance. Integrate multiple DeFi services unders 1 line of code.
  • Usual — Usual Labs operates as a decentralized finance(DeFi) protocol.
  • LayerZero Labs — An omnichain interoperability protocol. LayerZero enables the realization of cross-chain applications with a low level communication primitive.
Show all investments...

University of Zurich
VC Fund · Zürich, Zurich, Switzerland · 1 investments in Switzerland Life Science startups

The University of Zurich is one of the leading research universities in Europe and offers the widest range of degree programs in Switzerland.

Show more...

Investment focus

  • Industry: Health Care, Life Science, Biotechnology
  • Stage:Series A
  • Geography: Switzerland

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • MUVON Therapeutics — Muvon Therapeutics platform helps women with urinary incontinence and treats diseases based on skeletal muscle degradation, supporting them in their commitment to living a healthy life. The company's mode of contact is by mail, phone, and physical address.
Show all investments...

Skyviews Life Science
VC Fund · Lausanne, Vaud, Switzerland · 1 investments in Switzerland Life Science startups

Skyviews Life Science is a privately held advisory company specialised in personalised health.

Show more...

Investment focus

  • Industry: Biotechnology, Food and Beverage, Medical
  • Stage:Series B, Series A, Seed
  • Geography: United States, Switzerland, United Kingdom

Investor stats

  • Total investments: 14
  • Lead/follow: no public data

Portfolio highlights

  • one.bio — BCD Bioscience is an emerging biotechnology spinout from UC Davis that creates ingredients for food and biopharmaceutical applications. The company was founded in 2019 and is headquartered in Davis, California, United States.
  • Volumina Medical — Volumina is active in the field of tissue engineering and develops injectable 3D scaffolds for the reconstruction of volumes of soft tissues (fat, muscles, glandular tissues, supporting and connective tissues) that have been lost after tumor ablation, disease, trauma, or for purely esthetically purposes.
  • Vedanta Biosciences — Vedanta Biosciences is a developer of immunotherapies designed to treat immune-mediated and infectious diseases. The company's immunotherapies include a suite of proprietary assays to select pharmacologically potent strains, vast proprietary datasets from human interventional studies, and facilities for cGMP-compliant manufacturing ofrationally-defined bacterial consortia in powder form, enabling physicians to access live bacteria drug to treat autoimmune and inflammatory diseases easily.It was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Show all investments...

UZH Life Sciences Fund
VC Fund · Zürich, Zurich, Switzerland · 1 investments in Switzerland Life Science startups

The UZH Life Sciences Fund involves two equal partners: the UZH Foundation and the Novartis Venture Fund. It seeks donations from private individuals, foundations and companies for the strategic priorities of the University of Zurich.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Seed, Convertible Note
  • Geography: Switzerland

Investor stats

  • Total investments: 4
  • Lead/follow: no public data

Portfolio highlights

  • Occlufit — Occlufit is an occluder device that conforms to complex geometries and provides immediate sealing of cardiovascular defects.
  • Navignostics — Navignostics combines highly multiplex tumor imaging with advanced data analytics for personalized cancer treatments.
  • ImmunOs Therapeutics — ImmunOs Therapeutics AG is a clinical-stage biotechnology company focused on discovering and developing next generation and novel human immunomodulatory proteins with a role in both innate and adaptive immunity.Their mission is to develop the next generation of novel therapeutics that will improve the lives of patients with serious disease.
Show all investments...

LongeVC
VC Fund · Lugano, Ticino, Switzerland · 1 investments in Switzerland Life Science startups

With more than 30 portfolio companies across AI, pet health, ageing medicine and more, LongeVC provides venture capital for the biotech and longevity sectors.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Seed, Series A
  • Geography: United States, Estonia, Hong Kong

Investor stats

  • Total investments: 11
  • Lead/follow: no public data

Portfolio highlights

  • Melio — Melio has created a rapid, precise, and comprehensive blood test that identifies 99% of the most common pathogens in hours, rather than days.
  • Proton Intelligence — Continuous, real-time, and accurate biomarker monitoring to better manage chronic disease and save lives.
  • Catena Biosciences — Catena Biosciences uses a novel protein conjugation method to bring breakthroughs in biological therapeutics, autoimmune disorders and vaccine development
Show all investments...

AXA Alternative Investments
VC Fund · 1 investments in Switzerland Life Science startups

AXA IM Alts' strategies are based on strong convictions, with the goal of providing long-term value to customers, communities, and the world. AXA IM Alts is part of AXA Investment Managers.

Show more...

Investment focus

  • Industry: Agriculture, Biomass Energy, Renewable Energy
  • Geography: Kenya

Investor stats

  • Total investments: 4
  • Lead/follow: no public data

Portfolio highlights

  • Mombak — Mombak is a carbon removal company that focuses on the reforestation of the Amazon. The company's team combines experts in science, technology, forestry, and carbon markets
  • ReproNovo — New Scientific Approaches in Reproductive Medicine. At ReproNovo, we are passionate about bringing the dream of parenthood to life.
  • Chloris Geospatial — Chloris Geospatial is able to provide answers today to critical natural capital issues. Chloris Geospatial provides innovative measurements of natural capital that use cutting-edge remote sensing, machine learning, and ecological science.
Show all investments...

Mergus Ventures
VC Fund · Nova Lima, Minas Gerais, Brazil · 1 investments in Switzerland Life Science startups

Investing in unconventional founders solving challenges with cutting-edge, future-forward technologies.

Show more...

Investment focus

  • Industry: Biotechnology, AgTech, Artificial Intelligence
  • Stage:Seed, Pre-Seed
  • Geography: Brazil, United States, Chile

Investor stats

  • Total investments: 23
  • Lead/follow: no public data

Portfolio highlights

  • Spaceium — Spaceium develops a spacecraft docking system to support interplanetary missions. Its docking mechanism aims to offer solutions in the fields of In-space refueling with sustainable fueling stations can be an essential part of space exploration. The company's service hubs efficiently store and transfer cryogenic (extremely cold) andnon-cryogenic fuels with zero loss during storage and transfer.
  • Starcloud — Starcloud is building a network of megawatt-scale data centers in space, scaleable to gigawatt capacity. Falling launch costs allow Starcloud to take advantage of the abundant energy, passive cooling, and high-speed connectivity in space.
  • Starcloud — Lumen Orbit provides in-orbit cloud computing and data relay for satellites.
Show all investments...

OrbiMed
VC Fund · New York, New York, United States · 1 investments in Switzerland Life Science startups

Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A, Series C
  • Geography: United States, China, Israel

Investor stats

  • Total investments: 538
  • Lead/follow: no public data

Portfolio highlights

  • TandemAI — Streamline discovery with our integrated drug discovery platform, blending AI, physics-based tools, and wet lab for unparalleled innovation. Click now.
  • Epigenic Therapeutics — Epigenic Therapeutics is a biotech firm that offers gene editing therapy.
  • Pionyr Immunotherapeutics — Pionyr Immunotherapeutics is developing cancer immunotherapies that target the tumor microenvironment to enhance the body’s antitumor immunity. The company is exploiting novel target discovery and antibody generation platform technologies to create the next generation of immuno-oncology therapeutics. The company’s approach, Myeloid Tuning™, isdesigned to enhance the immune system’s anti-tumor response by altering the cellular infiltrate of the tumor microenvironment with high specificity.
Show all investments...

Pivotal bioVenture Partners
VC Fund · San Francisco, California, United States · 1 investments in Switzerland Life Science startups

Pivotal Life Sciences specializes in providing capital to innovative companies developing therapeutic products to address major unmet medical needs.

Show more...

Investment focus

  • Industry: Biotechnology, Pharmaceutical, Health Care
  • Stage:Series B, Series C, Series A
  • Geography: United States, China, Canada

Investor stats

  • Total investments: 34
  • Lead/follow: no public data

Portfolio highlights

  • Evommune — Evommune is taking a tissue-based approach to advance insights and accelerate the development of transformative medicines in inflammatory diseases.
  • Windward Bio — Windward Bio is a clinical-stage, drug development company committed to improving outcomes for people living with advanced immunological diseases.
  • Zenas BioPharma — Enabling patients with autoimmune diseases to reimagine life
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
RTW Investments
VC Fund · New York, New York, United States · 1 investments in Switzerland Life Science startups

We invest in biotech and medtech innovation across the full lifecycle from company creation to venture capital, alternative financing, and public companies.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Post-IPO Equity, Series B, Series C
  • Geography: United States, Switzerland, China

Investor stats

  • Total investments: 116
  • Lead/follow: no public data

Portfolio highlights

  • Belite Bio — Belite Bio focused on first-in-class therapeutics targeting untreatable inherited orphan diseases and age-related metabolic diseases, including atrophic age-related macular degeneration, stargardt disease, and nonalcoholic steatohepatitis. They develop anti-RBP4 therapies to treat age-related metabolic diseases, including macular degeneration,liver disease, and diabetes. Their technology platform effectively reduces circulating levels of RBP4, a vitamin A transporter protein linked to the development of aging metabolic diseases, including dry age-related macular degeneration, liver disease, and diabetes.
  • Umoja Biopharma — Pioneering immunotherapy by reprogramming T cells in vivo to target cancer cells.
  • Allurion Technologies — Allurion Technologies is developing a medical device for weight loss that can be delivered and removed without surgery or endoscopy.
Show all investments...

The Helm
VC Fund · New York, New York, United States · 1 investments in Switzerland Life Science startups

The Helm is the place to discover, shop, and fund female-identifying entrepreneurs.

Show more...

Investment focus

  • Industry: Health Care, Communities, E-Commerce
  • Stage:Seed, Series A
  • Geography: United States, Switzerland

Investor stats

  • Total investments: 35
  • Lead/follow: no public data

Portfolio highlights

  • Sway — Sway offers regenerative design solutions for plastic pollution using seaweed to create compostable replacements for single-use plastics. The company was co-founded by Julia Marsh, Matt Mayes, and Leland Maschmeyer and is headquartered in San Francisco, California, United States.
  • Testmate Health — 2 in 1 urine test with immediate results for Chlamydia trachomatis and Neisseria gonorrhoeae. Results within minutes & 100% anonymous.
  • itselectric — Itselectric partners with city property owners to unlock access to untapped electricity supply while they earn passive income.
Show all investments...

Recipharm Venture Fund
VC Fund · 1 investments in Switzerland Life Science startups

Recipharm Venture Fund is part of Recipharm AB.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Series A
  • Geography: Sweden, Switzerland

Investor stats

  • Total investments: 2
  • Lead/follow: no public data

Portfolio highlights

  • NewBiologix — NewBiologix operates as a technology innovation company, develops a proprietary and breakthroughDNA integration platform for the advanced engineering of human and mammaliancell lines.
  • Cinclus Pharma — A Swedish pharma company bringing relief to the world with the clinical stage drug candidate linaprazan glurate for gastric acid related diseases.
Show all investments...

Kickfund
VC Fund · Basel, Basel-Stadt, Switzerland · 1 investments in Switzerland Life Science startups

Kickfund is a Venture Capital fund that systematically backs companies that successfully complete Venture Kick.

Show more...

Investment focus

  • Industry: Biotechnology, Renewable Energy, Manufacturing
  • Stage:Seed, Pre-Seed, Convertible Note
  • Geography: Switzerland

Investor stats

  • Total investments: 22
  • Lead/follow: no public data

Portfolio highlights

  • BTRY — BTRY is a spin-off of EMPA and ETH and is developing the industry's first energy-dense solid-state battery, using sophisticated semiconductor manufacturing technologies.
  • Tethys Robotics — Tethys Robotics develops AI-powered application oriented robotics system that enables professionals in carrying underwater search & recovery to inspection & surveillance.
  • ASTRA Therapeutics — Astra - Therapeutics
Show all investments...

JFG Life Sciences Foundation
VC Fund · 1 investments in Switzerland Life Science startups

JFG Life Sciences Foundation is a non-profit foundation.

Show more...

Investment focus

  • Industry: Biopharma, Health Care, Biotechnology
  • Stage:Seed
  • Geography: Switzerland

Investor stats

  • Total investments: 2
  • Lead/follow: no public data

Portfolio highlights

  • Invasight — Invasight is a clinical biotech company that focused on revolutionizing cell invasion research. The company was founded in 2019 and is headquartered in Zurich, Switzerland.
  • NXI Therapeutics — NXI Therapeutics - Creating Tomorrow's Immunotherapies | The beginning of a new era of specificity and safety in the immunosuppressive therapy market
Show all investments...

Amboy Street Ventures
VC Fund · Los Angeles, California, United States · 1 investments in Switzerland Life Science startups

Amboy Street Ventures focuses on sexual health and women’s health technology startups. Amboy Street Ventures was founded in 2021 and was headquartered in Los Angeles, USA.

Show more...

Investment focus

  • Industry: Health Care, Wellness, Women's
  • Stage:Series A, Seed, Pre-Seed
  • Geography: United States, Canada, Sweden

Investor stats

  • Total investments: 17
  • Lead/follow: no public data

Portfolio highlights

  • Juniper Genomics — Juniper Genomics is shaping a better future for aspiring parents by enabling a faster, more successful IVF journey.
  • Nest Health — Nest Health is a primary care company that offers whole person, whole family care for families from birth through age five in urban areas. Nest offers primary and pediatric care for families, made affordable and convenient.
  • Allswell — Allswell is a queer-founded mental health platform dedicated to making affirming, accessible care available to the LGBTQ+ community, covered by Medicaid & major insurance.
Show all investments...

Simon Fiduciaria
VC Fund · Turin, Piemonte, Italy · 1 investments in Switzerland Life Science startups

Simon Fiduciaria nasce nel 1986 per prestare servizi fiduciari a importanti gruppi familiari, imprenditori e professionisti, a livello nazionale ed estero.

Show more...

Investment focus

  • Industry: Therapeutics, Simulation, Biotechnology
  • Stage:Seed, Series B
  • Geography: Italy, United Kingdom

Investor stats

  • Total investments: 7
  • Lead/follow: no public data

Portfolio highlights

  • MgShell — MgShell offers intraocular devices for the treatment of age-related macular degeneration and other ocular diseases. Their technology is the only technical solution capable of replicating current clinical practice with a single injection and releasing the same therapeutic drug doses at predetermined periods, autonomously and without surgicalprocedures.
  • Soource — Soource is a B2B Saas product that uses AI applications to help purchasing managers to discover the best market solutions through extensive global research and automated email negotiations with thousands of suppliers worldwide.
  • Annaida Technologies — Annaida Technologies has developed a groundbreaking device, EmbryoSpin, that performs microscopic Nuclear Magnetic Resonance (“µNMR”) at a scale 10-fold better than existing technologies.
Show all investments...

Ysios Capital
VC Fund · San Sebastian, Pais Vasco, Spain · 1 investments in Switzerland Life Science startups

Leading #lifesciences #venturecapital firm financing highly #innovative #biotechnology companies #worlwide.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: Spain, United States, Switzerland

Investor stats

  • Total investments: 77
  • Lead/follow: no public data

Portfolio highlights

  • ReproNovo — New Scientific Approaches in Reproductive Medicine. At ReproNovo, we are passionate about bringing the dream of parenthood to life.
  • Splice Bio — Splice Bio is a gene therapy company based on technology developed in the Muir Lab at Princeton University. The company is developing novel gene therapies based on its proprietary intein platform technology to treat patients that suffer from incurable genetic diseases. The company’s platform has the potential to address two existing limitations ofadeno-associated viruses (AAVs), both by increasing the size of the cargo gene that can be delivered and by expanding the range of tissues that can be targeted.
  • Synendos Therapeutics — Synendos Therapeutics is a biopharmaceutical company that aims to develop breakthrough safe and effective therapies for unmet needs in neuropsychiatric disorders through modulation of a new drug target in the endocannabinoid system that enables restoration of natural functioning of the brain.
Show all investments...

Primal Capital
VC Fund · Tokyo, Tokyo, Japan · 1 investments in Switzerland Life Science startups

Primal Capital, an independent venture capital " incubator bait fund at ", served as the Associate than July 2012 Hiroshi was Sasaki is the venture capital fund that serves as the representative partner. Representative of Sasaki, the seed acceleration program "Incubate Camp" operated by Incubate bait fund is carried out a totalof four times of planning and management than in 2012, They have also engaged in support operations of portfolio companies. - See more at: https://www.crunchbase.com/organization/primal-capital#sthash.m2z1DCbt.dpuf

Show more...

Investment focus

  • Industry: Software, Information Technology, Internet
  • Stage:Seed, Pre-Seed
  • Geography: Japan, Spain, Switzerland

Investor stats

  • Total investments: 30
  • Lead/follow: no public data

Portfolio highlights

  • Hivello — Hivello is a Decentralized Physical Infrastructure Network aggregator. Contribute resources, connect with Web3 protocols, and effortlessly generate passive income.
  • RemitAid — RemitAid is a fintech company that operates an overseas payment platform for cross-border transactions between companies.
  • xCARE — xCARE specializes in the development and commercialization phases of the pharmaceutical and medical device industries.
Show all investments...

Bruker
VC Fund · Madison, Wisconsin, United States · 1 investments in Switzerland Life Science startups

Bruker Corporation is a provider of high-performance scientific instruments and solutions for molecular and materials research, as well as for industrial and applied analysis.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Series A, Seed
  • Geography: United States, Switzerland

Investor stats

  • Total investments: 11
  • Lead/follow: no public data

Portfolio highlights

  • KIYATEC — Kiyatec is a functional precision oncology company that measures the response of individual patient live cancer cells with its innovative 3D cell culture technology platform. Kiyatec works with leading biopharmaceutical companies to unlock response dynamics for investigational drug candidates for use in solid tumors.
  • Terrain Bio — Terrain Bio helps RNA therapeutics companies design and build better RNA, faster. Leveraging the latest innovations in protein and RNA design and the deep expertise of its scientific cofounders, Terrain brings unparalleled speed and quality to RNA manufacturing.
  • Mercy BioAnalytics — We are making early stage cancer 100,000x easier to find using extracellular vesicles found in blood, specific to their parent cells.
Show all investments...

Life Science Investor funding in Switzerland at a glance

Stats across 119 deals from 182 investors.

182
investors
in Switzerland Life Science startups
119
deals
in Switzerland Life Science startups
$3.8M
median round
in Switzerland Life Science startups
40%
lead investors
lead at least one round
20%
Grant
most common funding stage
93/7
VC / Angel
share of investor count

Access all 182 investors in Switzerland Life Science startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Life Science Investors in Switzerland investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 182 investors investing in Switzerland Life Science startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists